At ASCO, Dr. Lucia Nappi presented on the management of post-chemotherapy residual disease in patients with metastatic testicular cancer. While cisplatin-based chemotherapy is highly effective, a subset of patients is left with residual masses that require further evaluation and management.

Her talk addressed current strategies for assessing these residual lesions, including imaging, tumor markers, and surgical resection when appropriate. She emphasized the importance of distinguishing between necrosis, teratoma, and viable cancer to guide further treatment decisions. The presentation also covered the role of multidisciplinary teams in optimizing outcomes and minimizing overtreatment.